Company Echo IQ Limited

Equities

EIQ

AU0000195430

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical Software & Technology Services

Market Closed - Australian S.E. Other stock markets 02:10:50 2024-06-11 am EDT			5-day change	1st Jan Change
0.18 ^AUD	+2.86%		+20.00%	+5.88%

May. 21	Echo IQ Launches Heart Failure Detection Study with AI	MT
May. 07	Echo IQ Lodges US FDA Application for EchoSolv Market Clearance; Shares Fall 4%	MT

EchoIQ Limited is an Australia-based artificial intelligence (AI) and medical technology company. It uses AI-driven technology and proprietary software to improve decision-making in cardiology. The principal activity of the Company is the development of AI products for cardiovascular care. The Company operates through two segments: Echo IQ and Houston We Have Software. The Echo IQ segment is engaged in developing products and services in medical technology. The Houston We Have Software segment offers products and services across other sectors. Its EchoSolv product allows users to assess echocardiographic studies against diagnostic guidelines for structural heart conditions. EchoSolv automatically identifies patients at risk of structural heart disease. EchoSolv improves the standard clinical workflow associated with diagnosis and treatment. The first two conditions addressed by the product are Aortic Stenosis and Mitral Regurgitation.

AUD in Million	2022	Weight	2023	Weight	Delta
Echo IQ 61.0 %	0	0.0 %	0	61.0 %	-
Houston We Have Software 39.0 %	0	100.0 %	0	39.0 %	-83.33%

AUD in Million	2022	Weight	2023	Weight	Delta
Australia 100.0 %	0	100.0 %	0	100.0 %	-57.26%

Managers	Title	Age	Since
Andrew Grover CEO	Chief Executive Officer	-	19-05-23
Seán Bryceland CTO	Chief Tech/Sci/R&D Officer	-	21-11-28
Philip Woolff COO	Chief Operating Officer	-	21-11-28
Geoffrey A. Strange CTO	Chief Tech/Sci/R&D Officer	-	-
David Playford PRN	Corporate Officer/Principal	-	21-05-31
Elizabeth Jennings SAM	Sales & Marketing	-	22-12-31
Dane Brescacin LAW	General Counsel	-	22-02-28
Deon Strydom PRN	Corporate Officer/Principal	-	22-02-28
Jessamyn Lyons SEC	Corporate Secretary	-	21-10-21
Donald L. Fowler PRN	Corporate Officer/Principal	-	22-09-30

Members of the board	Title	Age	Since
Stephen Picton BRD	Director/Board Member	-	21-10-19
Steven Formica BRD	Director/Board Member	65	18-07-01
Jessamyn Lyons		-	-
Simon Tolhurst BRD	Director/Board Member	-	23-05-31
Andrew Grover CEO	Chief Executive Officer	-	19-05-23

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	494,654,376	341,503,008 ( 69.04 %)	0	69.04 %

Name	Equities	%	Valuation
Alerte Digital Health Pte Ltd. 4.774 %	23,636,363	4.774 %	2 M $
Stephen Picton 4.396 %	21,764,854	4.396 %	2 M $
Simon Tolhurst 0.0242 %	120,000	0.0242 %	10 774 $

EchoIQ Ltd.

309 George Street Level 4

2000, Sydney

http://www.echoiq.ai

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Software & Technology Services

	1st Jan change	Capi.
ECHO IQ LIMITED	+5.88%	62.15M
PRO MEDICUS LIMITED	+33.63%	8.68B
SECTRA AB	+39.47%	4.56B
EVOLENT HEALTH, INC.	-30.00%	2.72B
VERADIGM INC.	-5.62%	1.61B
OMNICELL, INC.	-23.03%	1.34B
LUNIT INC.	-37.12%	1.08B
SIMULATIONS PLUS, INC.	+2.84%	929M
B-SOFT CO.,LTD.	-43.36%	791M
SURGICAL SCIENCE SWEDEN AB	-22.25%	675M

Medical Software & Technology Services